Royce & Associates »

Silverback Therapeutics shares owned by Royce & Associates

Quarter-by-quarter ownership of Silverback Therapeutics (SPRY) shares owned by Royce & Associates from 13F filings

Historical chart of Royce & Associates investment in Silverback Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silverback Therapeutics held by Royce & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silverback Therapeutics by Royce & Associates

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.6M 474k 5.48
2023-09-30 $1.8M 464k 3.78
2023-06-30 $3.1M 464k 6.70
2023-03-31 $2.0M 304k 6.51